newsfilter
← Latest News
PR Newswire·

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023

Highlighted significant research, preclinical advances and platform technology progress at third annual R&D Day Appointed Kristin Yarema, Ph.D., as President, Cell Therapy, adding extensive oncology and allogeneic T